课题基金 / 基金详情

项目摘要

项目成果

TED S ACOTT的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 青光眼是全世界6700万人失明的主要原因。高位眼内 眼压是青光眼的主要危险因素,降低眼压是目前唯一有效的治疗方法。 治疗各种形式的青光眼。小梁网邻近区域(JCT)内的细胞 可能与Schlemm氏管内壁内皮细胞(SCE)一起工作负责 强健的眼压稳态机制,在这种机制中,对房水流出的阻力通常在 对压力失衡的反应。青光眼的一个关键因素是眼压平衡能力的丧失。 这种房水流出阻力一直被认为是青光眼的主要因素。 发展,并已被广泛研究了超过65年,导致了大量不同的 改变它的调节和调节过程,包括一些最近的治疗剂。令人惊讶的是, 在正常人或青光眼患者中,这种耐药性的确切位置和分子组成都不清楚。 眼睛。毫不奇怪,制定有效的治疗方案来消除流出阻力是非常困难的。 功能障碍,当我们甚至不知道它是什么或在哪里。 此应用程序仅专注于识别和定位正常和非正常状态下的流出阻力 青光眼。 我们和其他许多人进行的实验和概念研究支持我们的工作假设,即 阻力主要存在于2m SC基底膜内,SC的直接贡献很小 内皮细胞本身。青光眼抵抗力的增加可能位于同一区域,并涉及 相同的分子,也可能不同。 我们提出了一套直接的研究,将定位这种耐药性和操纵,将确定 涉及到的分子。研究将主要在灌流的人类眼前节器官培养和 在我们最近开发的新的灌流眼前段楔形培养系统中。识别和 这种流出阻力的本地化将促进新的更有效的治疗青光眼眼压升高和 眼压平衡能力的丧失。
英文摘要
Project Summary Glaucoma is a major cause of blindness affecting over 67 million persons worldwide. Elevated intraocular pressure (IOP) is the primary risk factor for glaucoma and reducing IOP is the only current effective treatment for all forms of glaucoma. Cells within the juxtacanalicular region (JCT) of the trabecular meshwork (TM) probably working in conjunction with Schlemm's canal inner wall endothelium (SCE) are responsible for a robust IOP homeostasis mechanism in which the resistance to aqueous humor outflow is normally adjusted in response to pressure disbalances. A key component of glaucoma is the loss of this IOP homeostatic capability. This aqueous humor outflow resistance has long been recognized as a primary factor in glaucoma development and has been studied extensively for over 65 years resulting in a large number of diverse regulatory and modulatory processes to change it, including some recent therapeutic agents. Surprisingly, neither the exact location nor molecular composition of this resistance is known in normal or in glaucomatous eyes. Not surprisingly, it is very difficult to develop effective therapeutic resolutions to outflow resistance dysfunction, when we do not even know what or where it is. This application is narrowly focused on identifying and localizing the outflow resistance in normal and in glaucomatous eyes. Experimental and conceptual studies by us and many others support our working hypothesis that this resistance resides primarily within the 2 m SC basement membrane with a small direct contribution by the SC endothelial cells themselves. The glaucomatous resistance increase may reside in the same area and involve the same molecules, or it may not. We propose a set of direct studies that will localize this resistance and manipulations that will identify the molecules involved. Studies will be conducted primarily in perfused human anterior segment organ culture and in the new perfused anterior segment wedge culture system we have recently developed. Identifying and localizing this outflow resistance will facilitate new more effective therapies for glaucomatous IOP elevation and the loss of IOP homeostatic capability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Aqueous Humor Outflow Resistance
The Aqueous Humor Outflow Resistance
Mechanotransduction in Aqueous Outflow Regulation and Open Angle Glaucoma
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
海外基金